Summary
High-impact items this period
Cosmetic Specialty Labs, Inc.
CGMP violations in finished pharmaceutical production facility
Why: Manufacturing operations failed current good manufacturing practice requirements ·
Feb 29 ·
Impact: HIGH
Native Salts LLC
Unapproved drug marketed without required FDA authorization
Why: Product sold with unapproved claims and misbranded as pharmaceutical ·
Feb 28 ·
Impact: HIGH
Thai Nakorn Patana Co., Ltd.
CGMP violations in finished pharmaceutical manufacturing
Why: Manufacturing facility failed to meet current good manufacturing practice standards ·
Feb 27 ·
Impact: HIGH
Royal Philips
Medical device CGMP violations and adulterated products
Why: Manufacturing facility failed quality system regulations and CGMP standards ·
Feb 23 ·
Impact: HIGH
Innovative Formulations, LLC dba Insane Labz
Unapproved new drug marketed as finished pharmaceutical
Why: Product sold without FDA approval and misbranded labeling ·
Feb 22 ·
Impact: HIGH
Higley Industries, Inc.
Adulterated pharmaceutical product CGMP violations
Why: Manufacturing quality control and process deficiencies ·
Feb 22 ·
Impact: HIGH
LightEyez Limited
Finished pharmaceutical CGMP violations and unapproved new drug
Why: Manufacturing and marketing adulterated unapproved pharmaceuticals non-compliantly ·
Feb 15 ·
Impact: HIGH
Bell International Laboratories, Inc.
CGMP violations in finished pharmaceutical manufacturing
Why: Manufacturing facility failed to maintain current good manufacturing practices ·
Feb 15 ·
Impact: HIGH
Amman Pharmaceutical Industries
Finished pharmaceutical CGMP violations producing adulterated drugs
Why: Manufacturing finished pharmaceuticals in non-compliant conditions ·
Feb 14 ·
Impact: HIGH
EzriCare LLC
Finished pharmaceutical CGMP violations producing adulterated drugs
Why: Manufacturing finished pharmaceuticals in non-compliant conditions ·
Feb 13 ·
Impact: HIGH
Selected medium-impact items
The Vape Zone LLC
Tobacco product misbranding and adulteration violations
Why: Failure to comply with Family Smoking Prevention and Tobacco Control Act ·
Feb 29 ·
Impact: MEDIUM
Cencal Vape, Inc.
Tobacco product misbranding and adulteration violations
Why: Failure to comply with Family Smoking Prevention and Tobacco Control Act ·
Feb 27 ·
Impact: MEDIUM
Vapemarkdown.com
Tobacco product misbranding and adulteration violations
Why: Failure to comply with Family Smoking Prevention and Tobacco Control Act ·
Feb 27 ·
Impact: MEDIUM
Vapemoreinc.com, Inc.
Tobacco product misbranding and adulteration violations
Why: Failure to comply with Family Smoking Prevention and Tobacco Control Act ·
Feb 27 ·
Impact: MEDIUM
Vape Papa
Tobacco product misbranding and adulteration violations
Why: Failure to comply with Family Smoking Prevention and Tobacco Control Act ·
Feb 27 ·
Impact: MEDIUM
Get this delivered every week
Free tier: 3 items per vertical. Full access with paid subscription.
Subscribe — $29/mo →
Data sourced from public government APIs. AI analysis via Claude Haiku.
Full methodology →